Compare FATE & CRMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FATE | CRMT |
|---|---|---|
| Founded | 2007 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 125.6M | 103.5M |
| IPO Year | 2013 | 2026 |
| Metric | FATE | CRMT |
|---|---|---|
| Price | $1.71 | $11.13 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | $4.10 | ★ $29.50 |
| AVG Volume (30 Days) | ★ 3.0M | 82.9K |
| Earning Date | 05-14-2026 | 06-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 29.88 | ★ 147.36 |
| EPS | ★ N/A | N/A |
| Revenue | $6,646,000.00 | ★ $1,390,932,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.92 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.91 | $10.58 |
| 52 Week High | $2.47 | $62.55 |
| Indicator | FATE | CRMT |
|---|---|---|
| Relative Strength Index (RSI) | 49.44 | 38.65 |
| Support Level | $0.99 | $10.81 |
| Resistance Level | $1.94 | $13.56 |
| Average True Range (ATR) | 0.25 | 0.80 |
| MACD | -0.03 | -0.05 |
| Stochastic Oscillator | 39.76 | 20.70 |
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and, in the majority of cases, a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.